SCHEMBL8106728

SCHEMBL8106728

CCCCCC1=C(NC(=O)CCCC)C(=O)c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.56
PAX8 Q06710 1/20 0.56
HKDC1 Q2TB90 1/20 0.56
TLR9 Q9NR96 1/20 0.56
SOAT1 P35610 2/20 0.48
RAB9A P51151 3/20 0.47
GAA P10253 2/20 0.47
NPC1 O15118 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
PTPRC P08575 2/20 0.45
CETP P11597 2/20 0.45
ALDH1A1 P00352 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HDAC8 Q9BY41 4/20 0.43
HDAC3 O15379 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8100375 0.99 TDP2 (0.54) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8092735 0.96 TDP2 (0.57) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8102986 0.95 TDP2 (0.63) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8100889 0.93 TDP2 (0.61) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8108533 0.93 TDP2 (0.57) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8102458 0.91 TDP2 (0.53) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8092507 0.90 TDP2 (0.64) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8102847 0.90 RAB9A (0.53) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8092746 0.90 TDP2 (0.51) TDP2PAX8HKDC1TLR9SOAT1
SCHEMBL8100694 0.89 RAB9A (0.52) TDP2PAX8HKDC1TLR9SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013674-A INDENONE AMIDE DERIVATIVES, USEFUL FOR FOR THE INHIBITION OF LEUKOCYTE ADHERENCE TO ENDOTHELIAL CELLS; USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, AS ARTHRITIS, ASTHAMA, PSORIASIS, RESPIRATORY DISTRESS SYNDROME, STROKE AND ULCER ELI LILLY AND COMPANY (US) 2000-01-11 US disclosed
EP-0882706-A1 Cell adhesion inhibitors ELI LILLY AND COMPANY (US) 1998-12-09 EP disclosed